Last Updated: May 8, 2024   Image courtesy of aidsmap.com
     

 

 



 
Highlights

HIV Self-Test Kits and Prevention Tools: CDC’s Dr. Neblett Fanfair on 2024 CROI Highlights

HIV.gov | March 15, 2024

HIV.gov Blog: Week in Review - CROI 2024 Special Edition

HIV.gov | March 15, 2024

CROI 2024 Highlights: Conference on Retroviruses and Opportunistic Infections

ADAP | March 14, 2024

CDC’s Dr. Mermin Discusses HIV & STI Prevention Highlights from CROI 2024

HIV.gov | March 13, 2024

HIV Treatment Research and Key Takeaways: Dr. Dieffenbach's Final Update from CROI 2024 

HIV.gov | March 8, 2024

Monthly ART Injections Top Pills for HIV Patients With Adherence Problems 

Medpage Today | March 8, 2024

CROI2024: Day 3 Recap

HIV.gov | March 6, 2024

Children surpass a year of HIV remission after treatment pause

NIH | March 6, 2024

CROI2024: Day 1 Recap

HIV.gov | March 4, 2024

WHO @ CROI 2024

WHO | March 3-7 2024

   
Medication

Drugs that make HIV-infected cells self-destruct induce profound viral load drops in mice ... 

Aidsmap | May 3, 2024

PrEP Non-Persistence and New HIV Diagnoses: A Real-World Analysis of >120,000 People Prescribed PrEP

NATAP | CROI 2024 March 3-6 Denver

US States With More PrEP Coverage See Bigger Drops in HIV Diagnoses

NATAP | CROI 2024 March 3-6 Denver

Why Is Cabotegravir Rollout So Slow?

NATAP | CROI 2024 March 3-6 Denver

Semaglutide Effective for Metabolic-Associated Steatotic Liver Disease in HIV

Infectious Disease Advisor | March 21, 2024

Long-Acting ART for HIV Favored in Patients With Suboptimal Treatment Adherence

Infectious Disease Advisor | March 21, 2024

People who struggle with daily HIV regimen should be offered long-acting injections 

Healio | March 9, 2024

Watch HIV Researchers at CROI 2024 Discuss New Options for Long-Acting Treatment 

POZ Magazine | March 8, 2024

HIV Treatment Research and Key Takeaways: Dr. Dieffenbach’s Final Update from CROI 2024

HIV.gov | March 8, 2024

New Once-Daily HIV Oral Alternative Advances

Medscape | March 8, 2024

ViiV Healthcare announces interim data at CROI indicating superior efficacy of long-acting injectable HIV treatment Cabenuva compared to...

MarketScreener | March 7, 2024

Long-Acting HIV Treatment Benefits Adults with Barriers to Daily Pill Taking and Adolescents with Suppressed HIV

NIH | March 6, 2024

Once-weekly antiretrovirals on the horizon

Aidsmap | March 6, 2024

Investigational two-drug regimen safe, effective for patients with HIV

Healio | CROI2024 | March 6, 2024

Dapivirine ring and oral PrEP found safe for preventing HIV in pregnant women 

Contemporary OB/GYN | March 6, 2024

PrEP use up, HIV incidence down, data show

Healio | CROI2024 | March 5, 2024

Phase 1 Study of Cabotegravir Long-Acting Injectable Formulations Supports ≥4-Monthly Dose Interval

CROI | CROI 2024 March 3-6 Denver

   
News

A Randomized Trial Switching Adults ≥ 60 Years Old From First-Line ART to B/F/TAF: Week 48 Results

NATAP | CROI 2024 March 3-6 Denver

Disparities in HIV care among Hispanic/Latino persons by birthplace and social vulnerability-United States, 2021

NATAP | CROI 2024 March 3-6 Denver

Using the ICE Method to Examine Income/Racial Segregation and HIV Outcomes -US, 2021: structural racism

NATAP | CROI 2024 March 3-6 Denver

Community Advocates at #CROI2024 Condemn Appalling Behavior by Hundreds of Opening Plenary Attendees

EATG | March 7, 2024

   
Research

ICYMI: Research Roundup from CROI 2024

HIV.gov | May 1, 2024

Lung Function, HIV and Mortality: Analyses From the AIDS Linked to the Intravenous Experience Cohort: age 51, 81% black, 84% current smokers...

NATAP | March 4, 2024

   
Mental Health

Prevalence of diagnosed and undiagnosed depression among U.S. adults with HIV

NATAP | April 8, 2024

Life-Years Lost Associated With Mental Illness in People With HIV in South Africa and North America: anxiety, depression

NATAP | April 8, 2024

The Impact of the COVID-19 Pandemic on Substance Use Disorder Risk among People with HIV in the US

NATAP | April 1, 2024

TRENDS IN SUICIDE-RELATED EMERGENCY DEPARTMENT VISITS AMONG PEOPLE WITH AND WITHOUT HIV IN BRONX, NY...

NATAP | March 28, 2024

Socio-Demographics Were Stronger Classifiers of Cognitive Profiles Than Neuroimaging in HIV

NATAP | March 16, 2024

Progress Toward Achieving National Goals for Improved Quality-of-Life Among Black Women With HIV.....worse unmet mental health needs, self...

NATAP | March 13, 2024

TRENDS IN SUICIDE-RELATED EMERGENCY DEPARTMENT VISITS AMONG PEOPLE WITH AND WITHOUT HIV IN BRONX, NY

CROI 2024 March 3-6 Denver | courtesy of NATAP.org

   
Testing & Prevention

National HIV self-testing program finds high demand, many testing for first time

Healio | CROI | March 15, 2024

   
HIV & Aging

Associations between a polygenic risk score for Alzheimer's disease and brain integrity in HIV

NATAP | March 18, 2024

Aging & Perinatally Acquired HIV: Cardiometabolic Risks and Comorbidities: Adolescents and Young Adults with Perinatally...

NATAP | March 7, 2024

Age Modifies the Association Between Sex and the Plasma Inflammatory Proteome in Treated HIV

CROI 2024 March 3-6 Denver | courtesy of NATAP.org

Age-Adjusted Mortality Rates Among Persons With HIV, by Race and Ethnicity and Cause of Death....22% due to comorbidities

NATAP | CROI 2024 March 3-6 Denver

   
COVID-19

Dexamethasone Plus Remdesivir Dual Therapy Reduces Mortality in COVID-19

Infectious Disease Advisor | March 21, 2024

Study reveals why COVID-19 antibodies fade quickly

News Medical | March 18, 2024

COVID-19 hybrid immunity more protective than vaccination alone among people with HIV

Healio | CROI | March 13, 2024

SARS-CoV-2 protein detectable in COVID-19 patients up to 14 months after illness

Healio | CROI | March 4, 2024

   
Youth

Data Support Use of Long-Acting Antiretroviral Therapy in Adolescents With HIV

Infectious Disease Advisor | March 21, 2024

Four children achieve treatment-free HIV remission for 1 year

Healio | CROI2024 | March 8, 2024

HIV Scientists at CROI 2024 Discuss a Promising Study on Newborns

POZ | March 8, 2024

Study Shows Promising Outcomes with HIV Treatment Started Promptly After Birth

HIV.gov | March 7, 2024

NIH study finds long-acting ART safe for HIV suppression in adolescents 

Contemporary OB/GYN | March 7, 2024

Children Surpass a Year of HIV Remission after Treatment Pause

NIH | March 6, 2024

Study Shows HIV Remission Is Possible for Children Started on Very Early Antiretroviral Therapy 

Johns Hopkins Medicine | March 6, 2024

Injectable ART given every 8 weeks safely suppresses HIV in adolescents

Healio | CROI2024 | March 6, 2024

   
Medical

Leading Causes of Death Among People With HIV in the US, 2001-2019 4x greater death risk than gen. pop., cancer & heart disease, HIV leading...

NATAP | March 13, 2024

Prostate cancer characteristics and outcomes for veterans: Higher Advanced Prostate Cancer Risk in Veterans With Than Without HIV, 67% Blacks...

NATAP | March 13, 2024

Immunologic Factors Tied to Mpox Hospitalization Risk in Patients With HIV

Infectious Disease Advisor | March 21, 2024

2024 CROI Tuberculosis Research Round Up

TAG | March 14, 2024

Associations between Nadir CD4 and Subsequent Immune Measures with Long-Term Cognitive Function in HAILO (ACTG 5322)

NATAP | CROI 2024 March 3-6 Denver

Modifiable Factors Associated With Cardiovascular Disease Risk Among Women With and Without HIV

CROI 2024 March 3-6 Denver | courtesy of NATAP.org

InSTI Switch During Menopause Is Associated With Accelerated Body Composition Change

NATAP | CROI 2024 March 3-6 Denver

Tools Underestimate Cardiovascular Event Risk in People with HIV 

HIV.gov | March 4, 2024

Addressing Liver and Cardiovascular Disease among People with HIV and HIV Prevention During Pregnancy: Dr. Dieffenbach’s Second Update...

HIV.gov | March 6, 2024